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Abstract
Background: Gut microbial colonization and development of immune competence are intertwined and are
influenced by early-life nutritional, environmental, and management factors. Perturbation of the gut microbiome
at young age affects the crosstalk between intestinal bacteria and host cells of the intestinal mucosa.
Results: We investigated the effect of a perturbation of the normal early life microbial colonization of the
jejunum in 1-day old chickens. Perturbation was induced by administering 0.8 mg amoxicillin per bird per day)
via the drinking water for a period of 24 h. Effects of the perturbation were measured by 16S rRNA profiling of
the microbiome and whole genome gene expression analysis. In parallel to what has been observed for other
animal species, we hypothesized that such an intervention may have negative impact on immune development.
Trends were observed in changes of the composition and diversity of the microbiome when comparing
antibiotic treated birds with their controls. in the jejunum, the expression of numerous genes changed, which
potentially leads to changes in biological activities of the small intestinal mucosa. Validation of the predicted
functional changes was performed by staining immune cells in the small intestinal mucosa and a reduction in
the number of macrophage-like (KUL01+) cells was observed due to a direct or indirect effect of the antibiotic
treatment. We provide evidence that a short, early life antibiotic treatment affects both the intestinal microbiota
(temporarily) and mucosal gene expression over a period of 2 weeks.
Conclusion: These results underscore the importance of early life microbial colonization of the gut in relation
to immune development and the necessity to explore the capabilities of a variety of early life dietary and/or
environmental factors to modulate the programming for immune competence in broilers.
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Background
Nutrient intake and immune homeostasis are important
aspects for chicken health. These aspects are influenced
by many different factors, for instance by the composition
and diversity of the resident intestinal microbial popula-
tion, by feed composition and by host genetics [1, 2]. In
research, already quite a lot of attention is given to
genetics, housing, and diet, in order to generate vital
broilers, regarding their performance and immune compe-
tence. However, little attention was given so far to the role
of microbiota for healthy broilers [3, 4]. The colonization
of the gut by microbiota in young animals occurs simul-
taneously with the development of the gut tissues [3, 5–7].
Later in life, interactions between microbiota and mucosal
host cells influence the functioning of the gut system. This
intimate interplay affects digestion, maintenance of gut
barrier integrity, and immune homeostasis [8]. After
hatch, the immune system develops rapidly and also this
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development heavily influenced by the early life microbial
colonization of the gut. Dietary interventions at young
age, such as the usage of (pre)starter feeds, prebiotics, pro-
biotics and antibiotics, are regarded to affect the crosstalk
between microbiota and host mucosal cells in the intes-
tinal tract, which may result in a change of immune devel-
opment [8–11]. During the first weeks of life different
categories of immunological processes have been identi-
fied in broilers [12–14]. Based on spatio-temporal gene
expression profiles, the following sequential order for
immune related processes have been reported: 1) innate
development and influx of immune cells; 2) immune
differentiation and specialization; and 3) maturation and
immune regulation [14].
For pigs, it has already been shown that administration
of antibiotics during early life, day 4 or day 28 of age,
leads to altered composition and diversity of microbiota
in the gut [10, 11, 15]. These perturbations also affected
the expression of numerous immune related genes in
the gut mucosal tissue for a longer period of time (up till
56 days after treatment). This indicated an important
role for the early gut microbial colonizers for the devel-
opment and/or programming of the mucosal immune
system. In addition, studies in mice and humans show
that modulating the microbial colonization in early life
by antibiotics, can lead to higher risks for developing
immunity based disorders, such as asthma and allergy
[2, 16, 17]. Therefore, it is worthwhile to investigate the
importance of early life microbial colonization in
chicken on immune status, which is relevant for the de-
velopment of early life nutritional strategies to produce
vital broiler chicks, regarding their performance and
immune competence. In parallel to what has been ob-
served for other animal species, we hypothesized that
an early life intervention with an antibiotic may have
negative effects on immune development [2, 15, 18, 19].
We compared a non-disturbed microbial colonization
profile of control chicken with a disturbed microbial
colonization profile of chicken that received the antibiotic
(a dose of approximately 0.8 mg amoxicillin [=19 mg/kg
body weight/day]) at day 1 after hatch. Amoxicillin is a
broad-spectrum antibiotic of the penicillin family.
Amoxicillin is active against some Gram-negative and
most Gram-positive bacteria. However, amoxicillin is
not effective against beta-lactamase producing organ-
isms. For poultry this antibiotic is used in Europe, but
not in the United States. In Europe amoxicillin is used
for the treatment and prevention of bacterial infections.
In poultry this includes alimentary, urogenital and re-
spiratory tracts infections [20]. The recommended dose
(by the manufacturer) is 10 to 20 mg of the product per
kg of body weight (i.e. 8–16 mg/kg amoxicillin trihy-
drate) per day, and should be administered via the
drinking water. According to the recommendations of
the manufacturer, the product should be administered
for 3–5 consecutive days to be effective in preventing
clinical signs of disease. However, in this study we used
healthy animals and therefore we administered the
amoxicillin only once in order to perturb the intestinal
microbiome during early-life.
The objective of this study was to investigate the impact
of a short-term (24 h) perturbation of the normal early life
microbial colonization of the gut of broiler chickens with
an oral dose of amoxicillin on the diversity and compos-
ition of the intestinal microbiota over a period of 2 weeks.
In addition, we investigated the impact of the perturbation
on the host intestinal gene expression and the number
and identity of immune cells in the gut mucosal tissue
over the same period of time. To find out whether the
microbiota and host gene expression were altered by the
antibiotic treatment, we collected jejunal samples at three
time-points: day 1 after hatch (prior to antibiotic adminis-
tration); day 5; and day 14. From the jejunum the luminal
content was taken to perform in depth 16S rRNA sequen-
cing of the resident microbiota and jejunal tissue was
taken to perform genome wide gene expression analyses
and to characterize and quantify intestinal immune cells.
Methods
Housing, diet, and experimental design
In this experiment 1-day-old chickens (Cobb500, both
males and females) with an average body weight of
approximately 42 g at hatch, were housed in a floor pen
system with litter (wood shavings). Chickens had ad
libitum access to crumble feed and water. All treatment
groups and pens received feed from the same batch.
For each of the treatments, control or antibiotic, eight
pens were used. After the treatments chicks were housed
on fresh litter.
Representative feed samples were used for chemical
analyses, including the Kjeldahl method for nitrogen
determination and ashing at 550° Celsius to determine
the amount of ash (Table 1). We assumed that chickens
will consume approximately 0.012 L water the first day.
The antibiotic treatment (24 h) consisted of 0.067 g
amoxicillin per litre drinking water, which corresponds
to approximately 0.8 mg amoxicillin per bird per day
and to 19 mg amoxicillin per kg body weight per day,
as advised by the manufacture.
At three time-points during the study (days 1, 5, and 14)
birds were sacrificed for tissue sampling. Birds were first
anesthetised, followed by decapitation, the animal ethics
board advised and approved this procedure [21, 22]. At
day 1, before the antibiotic treatment, 80 chickens were
sacrificed. At days 5 and 14, 160 chickens were sacrificed,
80 control and 80 antibiotic treated chickens, respectively.
For gene expression studies the samples were taken
from mid-jejunum (whole tissue; 2–3 cm) and snap
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frozen in liquid nitrogen. The adjacent anterior part
(approximately 5 cm) was used for sampling the jejunal
microbiota (by extracting the luminal content and
directly deposit this into a tube) and also snap frozen in
liquid nitrogen. Lastly, the adjacent posterior part (whole
tissue; 2 cm) was snap frozen in liquid nitrogen and used
for immunohistochemistry. All the samples were stored at
-80 °C until further analyses.
Subsequently, for each combination of time-point and
treatment (5 groups) RNA or DNA of individual chickens
were pooled for further analysis. Pooling was performed
per pen, because this was the unit of interest. Per time-
point/treatment combination 10 RNA or DNA of indi-
vidual chickens made up a pool and in total there were
8 pools (see Fig. 1). Animals were pooled, because our
main focus was to get more insight into biological pro-
cesses (bacterial colonization, intestinal development)
at the population level.
Performance data
The performance of the animals was defined as body
weight or feed conversion ratio (FCR) per pen. Body
Table 1 Composition of the broiler diet
broiler starter diet














Enzyme (NSP degrading b) 0.02












6-phytase (PU d/kg) 500
Digestible lysine 11.2
Digestible methionine 5.4



















aPremix supplied per kg of feed. Vitamin A, 12 500 (internation unit (IU); Vitamin
D3 3500 IU; Vitamin Hy-D, 0.025 mg; Vitamin E, 100 IU; Vitamin K3, 4 mg; Vitamin
B1 4 mg; Vitamin B2 9 mg; Pantothenic acid 20 mg; Niacinamide, 70 mg; Vitamin
B6, 6 mg; Folate, 1.5 mg; Vitamin B12, 30 μg; Biotine 250, μg; Betaine, 150 mg; L-
Carnitine, 30 mg; Fe, 50.0 mg; I, 2.0 mg; Cu, 14.0 mg; Mn, 55 mg; Zn, 100 mg;
Se, 0.3 mg
bHostazyme X®
cPhyzyme® XP 5000 L
dPU, phytase units
Fig. 1 Schematic representation of experimental design. Eighty
birds were sacrificed at day 1, 5, 14 for control birds (without
antibiotic), WA1, WA5, and WA14 respectively, and at day 5 and 14
for antibiotic treated birds, A5 and A14 respectively. In total there
are 5 treatment-day combinations consisting of up to 8 points,
where each point represents 1 pool consisting of 10 chicken. The
antibiotic, amoxicillin, was administrated for 1 day, starting at day
1 and lasting for 24 h, via the drinking water. At all sampling days,
the jejunal segment was taken, for sequencing of the luminal
microbiota, host gene expression and immunohistochemical
staining of different immune cells
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weight was measured at days 5, 7, 14, 21, and 35. Whereas
the FCR was calculated over certain time periods, namely
0–5, 0–7, 0–14, 0–21, 0–35.
Microbiota data
For a detailed description see a previous study by
Schokker et al. [23]. Briefly, digesta of mid-jejunum was
collected for all birds, by gently stripping the gut segment
into a plastic container, and immediately snap-frozen in
liquid nitrogen and subsequently stored at -80 °C until
further analysis. DNA extraction was performed followed
by the V3 PCR sequencing and Quantitative Insights Into
Microbial Ecology (QIIME) pipeline [24]. Statistical
analysis were performed by the vegan package (http://
cran.r-project.org/web/packages/vegan/) within the R en-
vironment, i.e. Shannon diversity index and Redundancy
analysis (RDA). For over- and under-representation of
bacterial groups a (non-parametric) Wilcoxon signed-rank
test was performed on the family level, and p-values were
converted to false discovery rate (FDR) values to correct
for multiple testing. Where FDR values below 0.05 were
treated as significant, and FDR values between 0.05 and
0.1 as trends.
Transcriptomics data
For a detailed description see a previous study by Schokker
et al. [23]. Briefly, total RNA was extracted from 50 to
100 mg jejunum tissue. Jejunum is the intestinal seg-
ment of interest, mainly because the jejunum is both
involved in absorption of nutrients and minerals, exerts
immunological activity and in early life this segment is
involved in the programming of the (local) immune sys-
tem [13, 14]. Each sample was handled individually and
subsequently pools were made for further analyses.
Labelling, Hybridization, Scanning, and Feature Extrac-
tion were all performed as recommended by Agilent
Technologies. The data discussed in this publication have
been deposited in NCBI’s Gene Expression Omnibus [25]
and are accessible through GEO Series accession number
GSE67452 (https://www.ncbi.nlm.nih.gov/geo/query/acc.c
gi?acc=GSE67452). The data were analysed by using R
(v3.0.2) by executing different packages, including linear
models for microarray data (LIMMA) [26] and arrayQua-
lityMetrics [27]. On the data a background correction was
performed (method = “normexp” and offset = 1) with func-
tions from the R package LIMMA [26] from Bioconductor
[28]. Followed by quantile normalisation, thereafter dupli-
cate probes (probes mapping to the same gene) were aver-
aged (by performing the ‘avereps’ method). Subsequently,
the lower percentile of probes were removed in a three-
step procedure [23, 26]. Lastly, statistical and functional
genomics analysis were performed. To test the differences
between the experimental groups (without antibiotic and
antibiotics) on both day 5 and 14, the following
contrasts, A5-WA5 and A14-WA14, were generated
within the LIMMA package [26]. The Database for An-
notation, Visualization and Integrated Discovery (DA-
VID) was used to perform Functional Annotation
Clustering (FAC) for the two different contrasts, i.e.
A5-WA5 and A14-WA14. Up- and down-regulated
genes were separately analysed.
Immunohistochemistry
Jejunal cryosections, 8 μm thick, were stained with spe-
cific antibodies using an indirect immunoperoxidase
staining method as described by Schokker et al. [29].
Briefly, slides were treated for endogenous peroxidase
activity, blocked with BSA, and incubated with mono-
clonal antibodies against CD4+ cells, CD8+ cells, or
macrophage-like cells (CT-4, 1:200; CT-8, 1:200; and
KUL01, 1:50, respectively; Southern Biotech, Birmingham,
AL), followed by peroxidase-conjugated rabbit anti-mouse
Ig (P0161, Dako, Denmark). Peroxidase activity was de-
tected by 3,3-diaminobenzidine, and sections were coun-
terstained with haematoxylin. Negative controls were
performed by omitting of the primary antibody. For each
sample 3 to 4 mm2 mucosa (without muscular layers)
were evaluated by 10x magnification on a bright field
microscope. Subsequently, the samples were further ana-
lysed using Olympus cellSens Dimension (version 1.7.1)
software. First positive-stained cells were counted, sec-
ondly these cells were averaged per time point and group,
and lastly they were represented as positive-cells per tissue
area (square mm). A Student’s T-test was performed to
calculate the significance between the treatment and con-
trol on each time-point separately.
Results
Animal performance
Both the body weight and feed conversion ratio (FCR)
were not significantly different between antibiotic
treated birds and control birds. Body weights showed
an increase in time, from approximately 130 g at day 5
to 2.3 kg at day 34 (Table 2). The FCR also increased
over time, from approximately 0.78 at day 0–5 to
about 1.66 at day 0–34 (Table 3). A FCR below 1 is
Table 2 Body weight (g) at different time-points comparing
antibiotic versus control birds
Day WAa Ab SEM p-value*
5 132 129 1.0 0.18
7 181 188 2.9 0.25
14 501 505 6.2 0.75
21 950 960 11.9 0.69
34 2278 2276 44.2 0.98
a,bAbbreviations: WA without antibiotic; A with antibiotic
*Student’s t-test
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possible in broilers, because the chicks also absorb the
yolk sac in the first days of life [30].
Microbiota analyses
To get generic insight into the microbiota and relative
abundances of microbial groups over time, we selected the
top 9 most abundant bacterial groups (7 defined families)
over all three time-points in control birds (no antibiotics,
Table 4). This shows that the most dominant families,
based on their relative contribution, on day 1 were the
Enterobacteriaceae (61.1%) and Enterococcaceae (25.9%),
however for day 5 the most dominant families were the
Lactobacillaceae (77.9%) and Enterococcaceae (21.7%). At
day 14, again a shift in dominant families was observed
when compared to the previous recorded time-point. At
day 14 Lactobacillaceae (82.2%) and Streptococcaceae
(8.9%) were the most dominant families.
The microbiota diversity, calculated by the Shannon
diversity index, was based on the genus/species level data.
A decreasing trend in diversity was observed from day 1
(control) to day 5 (control, p = 0.08), whereas no signifi-
cant difference between day 1 (control) to day 5 (antibiotic
treated) (p = 0.32). From day 5 to day 14 an increasing
trend in diversity was observed for both the control and
antibiotic treated birds (p = 0.08 and p = 0.07, respectively)
(Fig. 2). To investigate the microbiota composition as a
whole, multivariate redundancy analysis (RDA) of the (ap-
proximate) family-level was performed, which showed a
clear separation of time (days of age and time after anti-
biotic treatment). In addition, a high overlap was observed
between the experimental treatments on each sampling
day (Fig. 3). At the first axis (x-axis) 39% of the variance is
explained and 10% of variance is explained at the second
axis (y-axis). To test whether specific microbial families
were significantly different between the treatment and
control birds on a specific time-point, a Wilcoxon signed-
rank test was employed. This resulted in eight significantly
different family groups (p < 0.05) for day 5, and three
significantly different family groups (p < 0.05) for day 14.
However, when multiple testing correction was taken into
account only three family groups remain for day 5, and for
day 14 no family groups were left (Table 5).
Transcriptomic analyses
Principal Component Analysis (PCA) was performed to
get insight into the variability in the jejunal transcripto-
mics data, taking into account the two treatment and
three time-points. Only the first and second principal
component were taken into account for both analyses,
accounting for 37% and 15% of the variance, respect-
ively. Figure 4 shows that clustering of the day/treatment
groups occurred only on days and not on treatments.
Furthermore, at this PCA level no within-days effects of
the antibiotic treatment could be observed. To investi-
gate the effect of the treatment in jejunum in more de-
tail, an Analysis of Variance (ANOVA) was performed.
All the probes (of which some with annotation) that
were significant under padj < 0.01 were identified. Probes
Table 3 Feed conversion ratio (FCR) of different time-slots of
antibiotic versus control birds
Time slot Average WAa Average Ab SEM p-value*
0–7 0.79 0.77 0.01 0.56
0–14 1.20 1.18 0.01 0.46
0–21 1.59 1.58 0.02 0.75
0–34 1.65 1.67 0.01 0.44
a,bAbbreviations: WA without antibiotic; A with antibiotic
*Student’s t-test
Table 4 Relative abundance of major bacterial groups in the jejunum at d 1, 5 and 14
Phylum Class Family WA1a WA5 A5b WA14 A14
Firmicutes Bacilli Enterococcaceae 25.9c 21.7 25.2 4.9 9.9
Firmicutes Bacilli Lactobacillaceae 0.5 77.9 74.2 82.2 70.5
Firmicutes Bacilli Leuconostocaceae <0.01 0.04 0.08 0.1 0.2
Firmicutes Bacilli Streptococcaceae 0.4 0.2 0.3 8.9 11.9
Firmicutes Clostridia Clostridiaceae 6.0 <0.01 0.01 0.2 0.2
Firmicutes Clostridia Otherd <0.01 <0.01 0.02 0.4 0.7
Firmicutes Erysipelotrichi Erysipelotrichaceae <0.01 0.05 0.05 0.04 0.7
Tenericutes Mollicutes <0.01 <0.01 <0.01 0.02 1.1
Proteobacteria Gammaproteobacteria Enterobacteriaceae 61.1 0.05 0.04 3.0 3.2
Unclassified 3.5 <0.01 <0.01 <0.01 0.2
Other 1.9 <0.01 <0.01 <0.01 0.1
Total 99.3 99.9 99.9 99.7 98.6
a,bAbbreviations: WA1 without antibiotic day 1; WA5 without antibiotic day 5; A5 with antibiotic day 5; WA14 without antibiotic day 14; A14 with antibiotic day 14
caverage relative contribution of 8 pools consisting of 10 chicken
dOther is a limitation of the underlying bioinformatics tool to further classify this as a certain family
In bold are the two most dominant families per time-point
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were also identified with a less stringent cut-off for the
statistical testing padj < 0.05, but including an absolute
Fold Change > 1 (Table 6). The annotated genes from
the padj < 0.01 list were taken for further functional and
enrichment analyses (Additional file 1). From these
lists, both the significant up- and down-regulated genes
were used as input for functional analyses which were
performed by using methods within the DAVID soft-
ware. This analysis resulted in multiple (range 11–172)
gene clusters with a significant Enrichment Score (ES).
The top 10 results from the DAVID functional annota-
tion clustering are summarized in Table 7 for the com-
parison between treatments on day 5 and in Table 8 for
the comparisons on day 14 (see also Additional file 2, for
full analysis). In general, the enrichment scores for day 5
were higher compared to those of day 14. At day 5 the
dominant terms of the down-regulated genes, i.e. lower
expression in the antibiotic treated birds, were related to
various immune processes, including ‘immune response-
regulating signal transduction’, ‘Positive regulation of im-
mune system process’, and’adaptive immune response’.
The up-regulated gene clusters of day 5, i.e. higher expres-
sion in the antibiotic treated birds, mainly encoded for
cellular processes, including ‘extracellular matrix’, ‘cell pro-
jection morphogenesis’, ‘regulation of cell development’,
and ‘EGF-like domain’. At day 14 the down-regulated
genes seemed to be involved in cellular processes, whereas
the up-regulated genes did not show a coherent picture.
Immunohistochemistry
To investigate whether the differences observed at the














WA1 WA5 A5 WA14 A14
Group
Fig. 2 Diversity of luminal microbiota in jejunum of broilers for
different experimental conditionsThe Shannon index (y-axis) was
calculated for all five experimental conditions (WA1, WA5, A5, WA14,
A14) (x-axis) based on the genus/species level. In total there are 5
treatment-day combinations consisting of up to 8 points, where each
point represents 1 pool consisting of 10 chicken. At each time point
eight measurements were performed, i.e. the spread depicted here is
the average between pens. Abbreviations: WA1, without antibiotic day
1; WA5, without antibiotic day 5; A5, with antibiotic day 5; WA14,
without antibiotic day 14; A14, with antibiotic day 14
Fig. 3 Redundancy analysis (RDA) of family level microbial groupsThe x-axis depicts explanatory axis 1 (RDA1) and y-axis depicts explanatory axis
2 (RDA2). Each condition is represented by a different colour (day 1, grey; day 5, where ‘WA’ is blue and ‘A’ is cyan; and day 14 where ‘WA’ is red
and ‘A’ is orange). In total there are 5 treatment-day combinations consisting of up to 8 points, where each point represents 1 pool consisting of
10 chicken. The grey arrows represent the environmental variables as constraining variables (i.e. the different microbial groups). In total there are
5 treatment-day combinations consisting of up to 8 points (pools), where each point represents 1 pool consisting of 10 chicken. The following
model was used as input for the RDA: y = Time + Treatment + Time* Treatment + error. Abbreviations: WA1, without antibiotic day 1; WA5, without
antibiotic day 5; A5, with antibiotic day 5; WA14, without antibiotic day 14; A14, with antibiotic day 14
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difference in the number and/or identity of immune cells
in the gut mucosal tissue, we analysed intestinal tissue sec-
tions for the presence of macrophage(-like) cells, CD4+
and CD8+ cells. Macrophage(-like) cells have a strong link
to innate immunity, whereas CD4+ and CD8+ have a
strong link to adaptive immunity. All measurements
were performed in jejunal mucosa tissues at days 1, 5,
and 14 (Fig. 5). The development of the innate and
adaptive immune system over time was shown by the
increasing number of cells per consecutive time-points.
Significant differences were observed between day 1
and 5 for CD4+ (p < 0.01), CD8+ (p < 0.001), and KUL01
+ (p < 0.001). Between day 5 and 14, only CD4+ (p <
0.001) and CD8+ (p < 0.001) were significantly different.
No significant difference was observed on days 5 and
14 when testing for the effect of the antibiotic treat-
ment in either CD4+ or CD8+ cells. However, for
KUL01+ cells (monocytes/macrophages) a significant
decrease in the treatment group (p < 0.001) was ob-
served on day 14.
Discussion
It is known that perturbation of intestinal microbial
colonization by antibiotic usage during early life influ-
ences immune development, e.g. children who received
antibiotics have higher incidence of allergy and asthma
[31–33]. Besides these seemingly negative effects on im-
mune development, one can imagine that it may also be
possible to positively modulate immune development by
providing specific diets or feed additives that influence
Table 5 Statistical testing of family level microbial groups by Wilcoxon signed-rank test
Day Phylum Class Family p-value* FDR
5 Firmicutes Bacilli Bacillaceae <0.01 0.04
Firmicutes Bacilli Carnobacteriaceae <0.01 0.04
Firmicutes Bacilli Leuconostocaceae <0.01 0.04
Actinobacteria Actinobacteria Nocardiopsaceae 0.02 0.11
Firmicutes Bacilli Thermoactinomycetaceae 0.02 0.11
Firmicutes Clostridia Ruminococcaceae 0.03 0.13
Actinobacteria Other Othera 0.04 0.15
Unclassified Other Other 0.05 0.15
14 Firmicutes Bacilli Enterococcaceae 0.01 0.24
Firmicutes Bacilli Lactobacillaceae 0.03 0.24
Firmicutes Clostridia Other 0.04 0.24
*Wilcoxon signed-rank test
















Fig. 4 Principal components analysis (PCA) of complete intestinal transcriptomics dataThe x-axis depicts principal component 1 (PC1) and y-axis
depicts principal component 1 (PC2). Each day is represented by a different symbol (day 1, square; day 5, circle; and day 14, triangle), and each
treatment within a particular day by a colour (day 1, grey; day 5, where ‘WA’ is blue and ‘A’ is cyan; and day 14 where ‘WA’ is red and ‘A’ is orange).
In total there are 5 treatment-day combinations consisting of up to 8 points, where each point represents 1 pool consisting of 10 chicken.
Abbreviations: WA1, without antibiotic day 1; WA5, without antibiotic day 5; A5, with antibiotic day 5; WA14, without antibiotic day 14; A14,
with antibiotic day 14
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the microbial colonization of the gut. In this paper we
provide evidence that a 24 h oral antibiotic treatment
during early life of broilers has a limited effect on the
microbial composition at day 5 after treatment, has a sig-
nificant effect on the intestinal gene expression profile
later in life (days 5 and 14), and a significant effect on the
number of macrophages (day 14) in intestinal mucosal tis-
sue. We expect the antibiotic effect to be greater than the
environmental effect. However, we do expect that the
housing system, i.e. floor pens (this study) or cages, could
have an effect on the ultimate microbiota composition.
In this study we investigated the local impact of an
antibiotic treatment in the gut. Therefore we sampled
jejunum for determining both gene expression and
microbiota profiling. The jejunum is important for the ab-
sorption of nutrients and harbours immune cells that are
important for monitoring luminal content (e.g. antigens).
However, one must realize that the jejunum forms part of
a larger complex ecosystem, the gastro-intestinal tract.
Antibiotics-induced changes may therefore also occur in
up- or downstream parts of the gastro-intestinal tract, for
example in the ileum or caecum. Furthermore, the ob-
served antibiotic-induced local changes may also trigger
differences in immune programming systemically. How-
ever, because of the lack of data, we cannot conclude
whether this occurs.
Microbial colonization and the effect of a short antibiotic
treatment
A few studies have been performed addressing the tem-
poral development of the most important colonizers of
the small intestine or caecum of chickens [3, 4, 34–36].
Here we observed that at day 1 the Enterobacteriaceae
and Enterococcaceae families were most abundant. At
day 5 the gut ecosystem shifted towards Lactobacillaceae
being most dominantly present followed by Enterococca-
ceae. At day 14 Lactobacillaceae were still the most
dominant family and Streptococcaceae were second most
abundant. This shows the generic succession of bacterial
families in the chicken gut over time, regardless of the
antibiotic treatment perturbation.
The diversity, as measured by the Shannon index,
showed a decreasing trend from day 1 (control) to day 5
(control) or no significant difference between day 1 (con-
trol) to day 5 (antibiotic treated). This was observed in
both control and antibiotic treated chickens and may be
due to the change in environmental conditions. At day 1,
chickens were transported by truck from the hatchery to
the experimental farm, this change of environment could
have accommodated stress which is known to affect
the gut microbiota and therefore the microbial diversity
[37, 38]. Another explanation might be that the decreasing
trend in microbiota diversity is due to the lack of feed in-
take during transport. An increasing trend of the diversity
from day 5 to 14 was observed for both the control and
antibiotic treated birds, this was expected because, in
Table 6 Descriptive statistics of gene expression data of
jejunum comparing antibiotic versus control on days 5 and 14
Comparison A5-WA5 a,b A14-WA14
Regulation Down Up Down Up
Number of probes
padj
c < 0.01 717 1156 457 354
padj < 0.05 and logFC
d > |1| 26 65 17 21
Number of annotated genes
padj < 0.01 489 556 182 234
padj < 0.05 and logFC > |1| 18 18 8 3
a,bAbbreviations: WA5 without antibiotic day 5; A5 with antibiotic day 5; WA14
without antibiotic day 14; A14, with antibiotic day 14
cAdjusted p-value (False Discovery Rate)
dlog Fold Change
Table 7 Functional annotation clustering (DAVID) of jejunum results (ES > 1.3) of the comparison antibiotic versus control on day
5 (padj < 0.01)
Down (lower in antibiotic treatment) Up (higher in antibiotic treatment)
ESa General Term ES General Term
4.83 intracellular organelle lumen 7.86 extracellular matrix
4.77 protein transport/localization 5.25 triple helix (hydroxyproline,hydroxylysine)
3.26 domain: BTB/POZ-like 5.16 Collagen triple helix repeat (hydroxyproline,hydroxylysine)
3.09 macromolecule/protein catabolic process 4.47 cell projection morphogenesis (neuron, differentiation)
2.65 immune response-regulating signal transduction 3.66 Fibrillar collagen
2.39 nuclear envelope-ER network 3.56 regulation of cell development (neuronal)
2.33 Pos. regulation of immune system process 3.08 positive regulation of transcription/macromolecule
2.27 cellular protein localization 3.07 EGF-like domain
2.19 adaptive immune response 2.57 response to steroid hormone stimulus (cortico/glucocortico)
2.08 Protease/peptidase activity 2.57 thrombospondin-type (Laminin G)
aES, Enrichment score
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general, the whole gut system develops towards a highly
diverse and more stable system, already partly reflecting
the ‘adult’ type microbiota [39–41].
When comparing the antibiotic treated chickens with
their respective controls, we only observed a numerical
increased diversity in the antibiotic group at day 5, that
was not notable anymore at day 14. This early life
antibiotic-driven increase in diversity was similar to
previous observation in pigs, showing that the micro-
bial diversity slightly increases and the microbial com-
munity structure becomes more chaotic [11, 15, 19].
Increase of diversity in an early life colonizing gut
system generates more chaos and is assumed to be
detrimental for immune development and therefore
“bad” [10]. Whereas increase of diversity in developed
“stable” gut systems is assumed to be associated with
improved resilience of that system.
When comparing the microbiota composition of the
antibiotic treated and control chickens, a high overlap was
observed for both day 5 and 14.. We expected long-lasting
changes based upon previous findings [15, 18, 42–44],
however in this experiment the gut microbiota ecosystem
apparently developed towards a steady state in 3 days after
the antibiotic treatment.
The impact of the antibiotic treatment could be ob-
served on the bacterial family level where minor
changes in average relative contribution (ARC) oc-
curred at day 5 and major changes on day 14. Lactoba-
cillaceae were more abundant at day 14 in controls
compared to the antibiotic treated chickens (p = 0.03,
FDR 0.24), 82.2% and 70.5% respectively. This suggests
that the early antibiotic treatment affected the micro-
bial colonization and composition/diversity over a long
period of time. This could be due to the antibiotic
treatment per se or to a shifting of the microbial eco-
system towards a different steady state (homeostasis).
Lactobacilli were used as probiotics in chicken to im-
prove intestinal health [45–47] and are reported to be
involved in competitive exclusion of pathogens [48–50],
however it has also been shown that they may have a
negative effect due to deconjugation of bile acids [51, 52].
This suggests that, in general, a high abundance of
Lactobacilli is favourable for intestinal health. Since the
abundance of Lactobacillaceae was decreased in the
antibiotic group, this also implies that a perturbation
with amoxicillin may have a negative effect on (gut)
health by the principle of competitive exclusion. In our
study, we observed a higher abundance of lactobacilli,
higher expression of immune related genes, and a
higher abundance of macrophage like cells, suggesting
that the latter may also contribute to improved health.
The higher abundance of Lactobacillaceae did, how-
ever, not translate into a measurable change in body
weight or feed conversion ratios, although the number
of animals (n = 8 pens per treatment group) might be too
low to draw firm conclusions on this aspect. At day 14, a
higher numerical abundance of Enterococcaceae was ob-
served in the antibiotic treated group (9.9% ARC) com-
pared to the control (4.9% ARC) chickens. This could be
due to the presence of intrinsic antibiotic resistance mech-
anisms [53] as have been described for Enterococcus
faecium and Enterococcus faecalis. Unfortunately, it was
not possible to check whether the Enterococci have anti-
biotic resistance gene cassettes present.
Functional genomics approach identifies (dis)similarities
between antibiotic treated and control chickens
The antibiotic treated chickens showed downregulation
of genes involved in immune related processes at day 5
and (generic) metabolic processes at day 14. Whereas,
upregulation of genes associated to cell structure/cell
cycle and developmental processes was observed in the
Table 8 Functional annotation clustering (DAVID) of jejunum results (ES > 1.3) of the comparison antibiotic versus control on day 14
(padj < 0.01)
Down (lower in antibiotic treatment) Up (higher in antibiotic treatment)
ES a General Term ES General Term
2.49 positive regulation of biosynthetic process/transcription 4.5 organelle lumen (intracellular)
2.00 epithelium morphogenesis/development 2.38 transit peptide/Mitochondrion
1.60 macromolecule/protein catabolic process 1.84 sterol/steroid biosynthesis
1.48 intracellular organelle lumen 1.68 Heat shock protein (DnaJ)
1.47 blood vessel development 1.53 RNA recognition motif (RNP-1)
1.51 translation initiation factor activity
1.48 (negative) regulation of lipid storage
1.43 Multiple Signalling Pathways (EPO/IGF1/IL6/TPO/IL2/PDGF/EGF)
1.39 cellular protein localization/targeting
1.32 zinc-binding (LIM domain)
a ES, Enrichment score
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antibiotic treated chickens at day 5. Similar observations
have been described for piglets after an antibiotic treat-
ment during early life. These antibiotic treated piglets
showed decreased mucosal gene expression profiles and a
subset of the down-regulated genes are involved in im-
mune related processes [11, 15, 19]. Our gene expression
data suggest that a perturbed microbial colonization in
the chicken gut leads to downregulation of immune re-
lated genes (including the following genes BCL10, PSEN1,
LYN, PSEN2, TLR4, TLR6, TLR7, C1QB, and C1S) and an
upregulation of genes linked to cell development and
intestinal barrier function (including FMOD, LTBP2,
HMCN1, WNT3, SMOC1, AGRN, ENTPD2, MUC2,
ZP1, NTN1, ADAMTS5, several genes involved in adhe-
sion, and many collagen genes). Functional analysis of the
down-regulated immune genes pointed towards a de-
crease or delay in the development of cell-mediated
immunity. Because under normal conditions cell-
mediated immunity develops immediately after hatch and
maturation occurs primarily in the first week [13, 14], this
decrease or delay maybe directly linked to the
microbiota-driven programming of the immune system.
The barrier function of the intestinal epithelium is the
first line of defence against intruders. Dysfunction of
the intestinal barrier leads to loss of epithelial integrity
and a higher risk for multiple gastrointestinal diseases
[54–57]. Altogether, the gene expression data suggested
that due to the antibiotic treatment, the developmental
“priorities” of the gut have shifted away from cell-
mediated immune development in favour of strength-
ening the gut barrier functions. This strategy of coping
with a perturbation during early life could be most cost
effective for the birds, because strengthening the intes-
















































































WA1 WA5 A5 WA14 A14
a
Fig. 5 Immunohistochemistry (IHC) staining of immune cells for the different treatments in time. In all graphs, the horizontal axis depicts the
experimental condition (treatment and time) and the vertical axis the number of cells per square millimetre of jejunal tissue. Left upper panel
depicts CD4+ cells, right upper panel shows the CD8+ cells, and the lower left panel represents the KUL01+ cells. In total there are 5 treatment-day
combinations consisting of up to 8 points, where each point represents 1 pool consisting of 10 chicken. At each time point eight measurements were
performed, i.e. the spread depicted here is the average between pens. Abbreviations: WA1, without antibiotic day 1; WA5, without antibiotic day 5; A5,
with antibiotic day 5; WA14, without antibiotic day 14; A14, with antibiotic day 14
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invasion of (pathogenic) microorganism. For the long
term this strategy may result in a reduced immune
competence of the birds.
When taken both the microbiota and transcriptomics
data together, the presented data suggest that an anti-
biotic treatment during early life only causes limited
changes in microbiota diversity and/or composition.
However, these limited and temporal changes may exert
a significant influence on immune programming. This
may be due to the fact that jejunum was chosen as the
tissue of interest, which has a less complex microbiota
composition and diversity compared to caecum, Shan-
non index 2.5 for jejunum and 5.5 for caecum [58]. We
still need more knowledge about this early life phase to
fully understand the gut (eco)system and its implication
towards the development and programming of the im-
mune system. Nevertheless, this is a first step in identify-
ing key components, e.g. microbial families or species,
which are involved in early life gut development.
Differences in immune cell populations due to the
antibiotic treatment
Development of the adaptive immune system in
broilers occurs in the first weeks of life [12–14]. Both
CD4+ and CD8+ cells increase significantly in number
in the small intestine from day 1 to 5 and day 5 to 14,
whereas the macrophage-like cells only significantly in-
crease in number at day 5. Here, we only investigated
the entire CD4+ population, which limits the interpret-
ation towards the ratio between Th1 and Th2 cells.
This ratio is important since it balances the systems be-
tween inflammation and antibody production [59]. To
our knowledge, the (in)direct effect of amoxicillin on
immune cells in healthy animals is not well described
yet, although it has been described that an beta lactam
antibiotic influences cytokine expression but not the
number of immune cells [60]. Our gene expression data
already suggested an effect of amoxicillin on immune
cells, because we observed differential expression of
genes like HLA-DRB1 (alias DR1), GSTT1, CYP19A1,
CXCL8 (alias IL8), and CRP (Additional file 1). All
these genes are involved in different aspects of cell-
based immunity [61–65]. These genes are involved in a
range of processes including antigen processing and
presentation, natural killer cell mediated cytotoxicity,
and hematopoietic cell lineage. It is tempting to specu-
late that the differences in these gene expression pro-
files translate into differences at the cellular level. With
regard to macrophages this was indeed the case. The
number of macrophages was significantly lower in anti-
biotic treated chickens on day 14 compared to control
chickens, whereas only a decreasing trend in the num-
ber of macrophage-like was observed on day 5. We
speculate that the downregulation of genes involved in
immune processes, as observed at day 5 in the anti-
biotic treated chickens, has a direct effect on the num-
ber of macrophages in later life. Another possibility is
that due to the augmented barrier function, chemo
attraction and/or influx of macrophages are reduced
under such conditions. Although we do not have any in-
formation on the activity of the macrophages, the conse-
quence of our observations could be that antibiotic
treated chickens have a reduced or altered innate immune
competence. Since innate and adaptive immunity are
intertwined, this may also affect adaptive immune re-
sponses later in life. The observed numerical decrease in
the number of CD4+ cells in the antibiotic treated birds
compared to control birds, is in agreement with this. The
number of CD8+ cells was not found to be affected by the
antibiotic treatment, suggesting a limited impact of the
antibiotic on this structural component of the adaptive
immune system.
Conclusion
Short term oral perturbation with an antibiotic during
early life of chickens affects microbial colonization and
intestinal immune development over a period of 2 weeks.
This was shown as a trend at the microbiota level
(composition and diversity), but significant at the gene
expression level in the mucosa of the small intestine.
Furthermore, we validated that the observed changes at
the gene expression level most probably lead to alterations
at the cellular immune level, i.e. changes in the number of
macrophage-like cells. Our data support the assumption
that early life colonization of the gut by microbiota is an
important driver of immune development and/or immune
programming, as has been found for other (mammalian)
species. However, we could not rule out direct effects of
amoxicillin on immunity. We conclude that it might be
worthwhile to explore the capabilities of a variety of early
life dietary and/or management factors modulate (indir-
ectly via the microbiota) immune competence develop-
ment of broilers. Furthermore, our data point towards
potential microbial, gene expression-based, and cell-based
indicators that might be used by animal nutrition indus-
tries for the development of innovative products to
optimize immune competence in broilers. Finally, our data
provide some preliminary insight into the mechanisms
underlying the increased risk for disease development
(predisposition of pathogenic bacterial species) associated
with early life usage of antibiotics. This usage leads to de-
creased expression of genes involved in immunological
processes at day 5 and subsequently lower number of
macrophage-like cells at day 14 in jejunum.
This work shows that it is possible to modulate the
microbiota via antibiotics with a negative impact on
immune development. Therefore, it may also be possible
to modulate the early life colonization of ‘beneficial’
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microbiota by the application of innovative dietary-based
or management measures. In this context it is worth men-
tioning that this study provides a valuable resource for the
identification of bacterial families of possible new pro-
biotic starter strains and/or targets for new early life prebi-
otics that may be developed in the future. Current pre-
and probiotics products, although also sometimes given
during early life, are mainly based on microbiota and
knowledge gained from adult birds [47, 66–68]. Probiotic
starter products based on the knowledge provided herein,
may be used to optimize early life immune development
and immune programming of poultry with the ultimate
aim to improve poultry’s immune competence.
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Additional file 1: Full analysis of differential expressed genes. The
Additional File (presented as.xlsx) contains multiple worksheets, where
the first worksheet describes the data present in the other four
worksheets. Worksheets 2 and 3 contain the full LIMMA results for
respectively the contrast A5-WA5 and A14-WA14. Whereas worksheets 4
contains the gene names (p < 0.01) which were used a input for DAVID
functional annotation clustering. Worksheet 5 contains probes (genes)
which were below adjusted p-value of 0.05 and had a Fold Change (FC)
above 1 or below -1. (XLSX 4618 kb)
Additional file 2: Full analysis of functional annotation clustering. The
Additional File (presented as.xlsx) contains multiple worksheets, where
the first worksheet describes the data present in the other five worksheets.
Worksheets 2–5 contain the full DAVID functional annotation clustering
results for the contrast A5-WA5 (up- and down-regulated genes) and A14-
WA14 (up- and down-regulated genes). Whereas worksheets 4 contains the
gene names (p < 0.01) which were used a input for DAVID functional
annotation clustering. Worksheet 5 contains probes (genes) which were
below adjusted p-value of 0.05 and had a Fold Change (FC) above 1 or
below -1. (XLSX 5707 kb)
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